Neuropace, Inc. Common Stock (NPCE) is a publicly traded Healthcare sector company. As of May 21, 2026, NPCE trades at $15.33 with a market cap of $545.16M and a P/E ratio of -24.63. NPCE moved +2.43% today. Year to date, NPCE is +2.59%; over the trailing twelve months it is -9.56%. Its 52-week range spans $5.45 to $19.60. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces NPCE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NPCE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $15.33 |
| Market Cap | $545.16M |
| P/E Ratio | -24.63 |
| EPS | $-0.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.60 |
| 52-Week Low | $5.45 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $99.53M |
| Net Income | $-21.57M |
| Gross Margin | 78.29% |
4 analysts cover NPCE: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.